Scientists probe eye fluid secrets to personalize glaucoma treatment
NCT ID NCT04412096
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the eye produces and drains fluid to understand why glaucoma medications lower eye pressure more in some people than others. Researchers measured eye fluid production, drainage, and pressure in 59 adults with glaucoma or high eye pressure before and after treatment with timolol or latanoprost eye drops. The goal is to find factors that predict a patient's response to these drugs, moving away from a trial-and-error approach.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Timolol 0.5% eye drops and Latanoprost 0.005% eye drops
What this could lead to
If successful, this could help doctors predict which glaucoma drug will work best for each patient, leading to more personalized and effective treatment.
What could go wrong
This is a small, completed study focused on understanding eye pressure factors, not on proving a new treatment works. The findings may not lead to immediate changes in clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
The Ohio State University
Columbus, Ohio, 43212, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68105, United States